Attention deficit hyperactivity disorder in the light of the epigenetic paradigm

Carregando...
Imagem de Miniatura
Citações na Scopus
45
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
SCHUCH, Viviane
UTSUMI, Daniel Augusto
MUSZKATI, Mauro
Citação
FRONTIERS IN PSYCHIATRY, v.6, article ID 126, 7p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Attention deficit hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder characterized by a definite behavioral pattern that might lead to performance problems in the social, educational, or work environments. In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, the symptoms of ADHD were restricted to those associated with cognitive (attention deficit) and behavioral (hyperactivity/impulsivity) deficits, while deficient emotional self-regulation, a relevant source of morbidity, was left out. The etiology of it is complex, as its exact causes have not yet been fully elucidated. ADHD seems to arise from a combination of various genetic and environmental factors that alter the developing brain, resulting in structural and functional abnormalities. The aim of this paper was to review epigenetics and ADHD focused on how multidimensional mechanisms influence the behavioral phenotype.
Palavras-chave
ADHD, executive functions, emotional self-regulation, DESR, genetic factors, environmental factors, epigenetics
Referências
  1. Achenbach T. M., 2000, MANUAL ASEBA PRESCHO
  2. Akutagava-Martins GC, 2014, AM J MED GENET B, V165, P502, DOI 10.1002/ajmg.b.32253
  3. American Psychiatric Association, 2013, DIAGN STAT MAN MENT
  4. Pagani LS, 2014, NEUROSCI BIOBEHAV R, V44, P195, DOI 10.1016/j.neubiorev.2013.03.008
  5. Stefanatos GA, 2007, NEUROPSYCHOL REV, V17, P5, DOI 10.1007/s11065-007-9020-3
  6. Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768
  7. Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021
  8. Brophy K, 2002, MOL PSYCHIATR, V7, P913, DOI 10.1038/sj.mp.4001092
  9. Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412
  10. Becker K, 2008, J PEDIATR, V152, P263, DOI 10.1016/j.jpeds.2007.07.004
  11. Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4
  12. van Meel CS, 2011, J CHILD PSYCHOL PSYC, V52, P942, DOI 10.1111/j.1469-7610.2010.02352.x
  13. Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7
  14. Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925
  15. Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279
  16. Kebir O, 2009, J PSYCHIATR NEUROSCI, V34, P88
  17. Wallis D, 2008, J PEDIATR PSYCHOL, V33, P1085, DOI 10.1093/jpepsy/jsn049
  18. Sharp SI, 2009, NEUROPHARMACOLOGY, V57, P590, DOI 10.1016/j.neuropharm.2009.08.011
  19. Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x
  20. Heath CJ, 2009, NEUROPHARMACOLOGY, V56, P254, DOI 10.1016/j.neuropharm.2008.07.020
  21. LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121
  22. Purkayastha P, 2015, CURR MED CHEM, V22, P1850
  23. Rizzutti S, 2008, ARQ NEURO-PSIQUIAT, V66, P821, DOI 10.1590/S0004-282X2008000600009
  24. Barkley RA, 2013, J CLIN CHILD ADOLESC, V42, P161, DOI 10.1080/15374416.2012.734259
  25. Class QA, 2014, PSYCHOL MED, V44, P71, DOI 10.1017/S0033291713000780
  26. Kim P, 2013, NEUROCHEM RES, V38, P620, DOI 10.1007/s11064-012-0960-5
  27. Thapar A, 2007, PSYCHOL MED, V37, P1681, DOI 10.1017/S0033291707000773
  28. Ptacek R, 2011, MED SCI MONITOR, V17, pRA215
  29. Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x
  30. Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143
  31. McGowan PO, 2010, NEUROBIOL DIS, V39, P66, DOI 10.1016/j.nbd.2009.12.026
  32. Miller EM, 2014, PSYCHOPHARMACOLOGY, V231, P3019, DOI 10.1007/s00213-014-3479-4
  33. Spencer TJ, 2011, POSTGRAD MED, V123, P50, DOI 10.3810/pgm.2011.09.2459
  34. Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006
  35. Hess EJ, 1996, J NEUROSCI, V16, P3104
  36. Marx I, 2010, J NEURAL TRANSM, V117, P403, DOI 10.1007/s00702-009-0345-3
  37. Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023
  38. Arcos-Burgos M, 2004, AM J HUM GENET, V75, P998, DOI 10.1086/426154
  39. Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112
  40. Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4
  41. Weyandt L, 2013, DEV NEUROPSYCHOL, V38, P211, DOI 10.1080/87565641.2013.783833
  42. Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008
  43. Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011
  44. Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716
  45. Sprich S, 2000, J AM ACAD CHILD PSY, V39, P1432, DOI 10.1097/00004583-200011000-00018
  46. Nelson ED, 2011, NEUROBIOL LEARN MEM, V96, P53, DOI 10.1016/j.nlm.2011.02.015
  47. Nishioka SA, 2011, REV PSIQ CLIN-BRAZIL, V38, P34
  48. Banerjee E, 2006, AM J MED GENET B, V141B, P361, DOI 10.1002/ajmg.b.30296
  49. Biederman J, 2012, NEUROPSYCH DIS TREAT, V8, P267, DOI 10.2147/NDT.S29670
  50. Webb E, 2013, ARCH DIS CHILD, V98, P397, DOI 10.1136/archdischild-2012-303578
  51. Hebebrand J, 2006, MOL PSYCHIATR, V11, P196, DOI 10.1038/sj.mp.4001761
  52. Paclt I, 2010, NEUROENDOCRINOL LETT, V31, P131
  53. Surman CBH, 2011, AM J PSYCHIAT, V168, P617, DOI 10.1176/appi.ajp.2010.10081172
  54. He F, 2011, SEMIN NEUROL, V31, P470, DOI 10.1055/s-0031-1299786
  55. Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604
  56. Heath CJ, 2010, PHYSIOL BEHAV, V101, P764, DOI 10.1016/j.physbeh.2010.08.021
  57. Romanos M, 2008, MOL PSYCHIATR, V13, P522, DOI 10.1038/mp.2008.12
  58. Neuman RJ, 2007, BIOL PSYCHIAT, V61, P1320, DOI 10.1016/j.biopsych.2006.08.049
  59. Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008
  60. Mill J, 2002, AM J MED GENET, V114, P269, DOI 10.1002/ajmg.10253
  61. Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878
  62. COOK EH, 1995, AM J HUM GENET, V56, P993
  63. Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139
  64. Kahn RS, 2003, J PEDIATR-US, V143, P104, DOI 10.1016/S0022-3476(03)00208-7
  65. Rinsky JR, 2011, CHILD NEUROPSYCHOL, V17, P368, DOI 10.1080/09297049.2010.544649
  66. Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65
  67. Bellgrove MA, 2005, EXP BRAIN RES, V163, P352, DOI 10.1007/s00221-004-2180-y
  68. Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024
  69. O'Brien JW, 2010, ARCH CLIN NEUROPSYCH, V25, P656, DOI 10.1093/arclin/acq050
  70. Roman T, 2002, AM J MED GENET, V114, P154, DOI 10.1002/ajmg.10194
  71. Latham KE, 2012, EPIGENOMICS-UK, V4, P383, DOI [10.2217/epi.12.31, 10.2217/EPI.12.31]
  72. Archer T, 2011, J GENET SYNDR GENE T, V2, P104, DOI 10.4172/2157-7412.1000104
  73. Asherson P, 2008, MOL PSYCHIATR, V13, P514, DOI 10.1038/sj.mp.4002140
  74. Faraone SV, 2008, AM J MED GENET B, V147B, P1387, DOI 10.1002/ajmg.b.30631
  75. Kent Lindsey, 2004, Curr Psychiatry Rep, V6, P143, DOI 10.1007/s11920-004-0054-4
  76. Marques SCF, 2011, PROG NEURO-PSYCHOPH, V35, P348, DOI 10.1016/j.pnpbp.2010.08.008
  77. Muszkat M, 2011, TRANSTORONTO DEFICIT
  78. Pires Tde O, 2013, BMC PSYCHIATRY, V13, P215
  79. Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942
  80. Purper-Ouakil D, 2011, PEDIATR RES, V69, p69R, DOI 10.1203/PDR.0b013e318212b40f
  81. Todd RD, 2007, AM J MED GENET B, V144B, P971, DOI 10.1002/ajmg.b.30640
  82. van Mil NH, 2014, J PSYCHIATR RES, V49, P51, DOI 10.1016/j.jpsychires.2013.10.017
  83. Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226